The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Rhonda Lewis et al.|PLoS ONE|2020Cited by 82
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Tithi Ghosh et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 19
Abstract 3869: The reversible LSD1 inhibitor SP-2509 promotes anti-tumor immunity in small cell carcinoma of the ovary-hypercalcemic type (SCCOHT)Raffaella Soldi, Sunil Sharma, Alexis Weston et al.|Cancer Research|2019Cited by 3